Medical Science News

RSS

Terumo Blood and Cell Technologies partners with TrAMPoline Pharma to automate TIL therapy manufacturing for solid tumors

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company advancing blood- and cell-based therapies worldwide, has entered a research collaboration with TrAMPoline Pharma and Eduardo Davila, PhD, at the University of Colorado to develop an automated manufacturing approach for tumor-infiltrating lymphocyte (TIL) therapies targeting solid tumors.

6 Oct 2026

Before the first bite: A missing gut protein may set the stage for peanut allergy

For most people, a peanut butter sandwich poses no threat.

6 Oct 2026

Tau modifications shape filament structures in neurodegenerative diseases

In neurodegenerative diseases such as Alzheimer's disease, progressive neuronal damage is associated with the accumulation of abnormal tau filaments in the brain.

6 Oct 2026

Lipid signaling pathway helps cells survive bacterial toxin damage

Epithelial cells form the body's frontline barriers, helping keep microbes, toxins, and other harmful substances out.

5 Oct 2026

Ultraprocessed meals produce distinct metabolic and brain responses

Most nutrition science suggests that meals with the same basic nutritional profile will have the same impact on a person's blood sugar.

5 Oct 2026

New BCR analysis method tracks immune recovery after stem cell transplantation

A research team led by Associate Professor Yohei Funakoshi, Associate Professor Kimikazu Yakushijin, and Professor Hironobu Minami of the Division of Medical Oncology/Hematology at Kobe University Hospital, together with Associate Professor Goh Ohji of the Division of Infectious Disease Therapeutics and Takaji Matsutani of Anymics Inc., has developed the pGen-SHM plot.

5 Oct 2026

New AI system automates classification of skin lesions

Skin cancer is a global health challenge, with nearly 1.5 million new cases diagnosed in 2024 according to World Health Organization (WHO) data. In response, the University of Alicante (UA) and the Sant Joan d'Alacant University Hospital have collaborated to launch MEL-IA (MobilE skin Lesion dIAgnosis), an artificial intelligence system designed to automate the classification of skin lesions.

5 Oct 2026

Restoring cellular recycling helps the body clear harmful zombie cells

As we grow older, our bodies accumulate "zombie cells"-living cells that have stopped dividing or functioning normally-but linger in our tissues, contributing to chronic inflammation and age-related diseases.

5 Oct 2026

Existing drug could target neuroinflammation in Alzheimer's patients

Inflammatory conditions in the brain, including traumatic brain injury and degenerative diseases like Alzheimer's could be targeted with an existing drug thanks to new research that shows it can work in brain cells.

5 Oct 2026

Doctors faced an AI-use penalty after disclosing AI use to patients

A study reveals that AI use by doctors can lead to negative perceptions, especially among younger patients, impacting trust and willingness to follow advice.

5 Oct 2026

Simple urine test can accurately diagnose and track bladder cancer

A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose people with bladder cancer more accurately than current standard methods.

5 Oct 2026

Is a high-protein diet hard on your kidneys?

From temporary changes in kidney filtration to the competing nutritional needs of older adults and children, researchers examine when high protein intake may shift from adaptation to concern.

5 Oct 2026

Working nights for years is linked to changes in body-clock genes

Chronic night shifts alter circadian gene activity in female healthcare workers.

5 Oct 2026

Poor nutrition scores predict mortality risk beyond body weight

In a population-based cohort of 8,398 adults in Leipzig, Germany, poorer nutritional status measured using several laboratory-based scores was associated with a higher risk of all-cause mortality over a median follow-up of about 7.5 years.

5 Oct 2026

Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the publication of new research in Nature Biotechnology describing an improved calibration framework for deep learning-based genetic perturbation models.

From Shift Bioscience 5 Oct 2026

Five lipids revealed a divide between active and inactive pregnancies

Staying active during pregnancy is linked to changes in DHA-rich placental lipids

5 Oct 2026

Dr. GPCR and Eurofins Discovery join forces to advance GPCR drug discovery

Dr. GPCR, the global knowledge hub for G protein-coupled receptor (GPCR) research and education, today announced a strategic partnership with Eurofins Discovery, the drug discovery services side of the same group behind the Eurofins DiscoverX products many in the community already know.

From Dr. GPCR 5 Oct 2026